Tandem Diabetes Care Inc (TNDM)

0.79
NASDAQ : Health Care
Prev Close 0.83
Day Low/High 0.78 / 0.85
52 Wk Low/High 0.76 / 8.81
Avg Volume 458.40K
Exchange NASDAQ
Shares Outstanding 49.84M
Market Cap 41.37M
EPS -2.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Tandem Diabetes Care Reports First Quarter 2017 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the quarter ended...

Tandem Diabetes Care To Present At The Deutsche Bank 42nd Annual Health Care Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will...

Tandem Diabetes Care Schedules First Quarter 2017 Earnings Press Release And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its first quarter 2017 results after the...

Tandem Diabetes Care Launches New T:connect Diabetes Management Application Portal For Healthcare Providers

Tandem Diabetes Care ®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the launch of the t:connect ® HCP Portal.

Tandem Diabetes Care Announces Pricing Of Underwritten Public Offering Of Common Stock

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the pricing of an underwritten public offering...

Tandem Diabetes Care Announces Filing Of Registration Statement For Proposed Follow-on Public Offering Of Common Stock

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it has filed a registration statement on...

Tandem Diabetes Care Reports 2016 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the year and quarter...

Tandem Diabetes Care Announces Plans For Improved Infusion Set Connector Developed From Customer Feedback

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced plans to implement a new infusion set...

Tandem Diabetes Care Launches First Ever Remote Software Update For Insulin Pump Using A Personal Computer

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the release of a software update for...

Tandem Diabetes Care Schedules Fourth Quarter And Full Year 2016 Earnings Press Release And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its fourth quarter and full year 2016 results...

Data Presented At ATTD 2017 Demonstrate Clinical Advantages Of Tandem Diabetes Care Sensor-augmented Pump (SAP) Over Medtronic MiniMed SAPs

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today presented study results comparing retrospective user...

Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers

Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers

CoLucid Pharmaceuticals saw shares boost 32% ahead of the market open Wednesday.

Tandem Diabetes Care To Draw Down $35 Million Under Existing Term Loan Facility With CRG

Tandem Diabetes Care To Draw Down $35 Million Under Existing Term Loan Facility With CRG

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) today announced that it has initiated the drawdown of $35 million under the company's previously announced term loan facility with Capital Royalty Partners II L.

Tandem Diabetes Care To Present At The 28th Annual Piper Jaffray Healthcare Conference

Tandem Diabetes Care To Present At The 28th Annual Piper Jaffray Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ:TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will...

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

(Graphic: Business Wire)

(Graphic: Business Wire)

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.

Tandem Diabetes Care Enters Oversold Territory (TNDM)

Tandem Diabetes Care Enters Oversold Territory (TNDM)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Tandem Diabetes Care Reports Third Quarter 2016 Financial Results

Tandem Diabetes Care Reports Third Quarter 2016 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the quarter ended...

Tandem Diabetes Care Announces Earlier Date For Q3 2016 Earnings Results And Conference Call

Tandem Diabetes Care Announces Earlier Date For Q3 2016 Earnings Results And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, now plans to release its third quarter 2016 results after the...

Commit To Buy Tandem Diabetes Care At $5, Earn 10.1% Annualized Using Options

Commit To Buy Tandem Diabetes Care At $5, Earn 10.1% Annualized Using Options

Investors eyeing a purchase of Tandem Diabetes Care Inc stock, but tentative about paying the going market price of $6.75/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2017 put at the $5 strike, which has a bid at the time of this writing of 20 cents.

Tandem Diabetes Care Now Shipping Next-Generation T:slim X2 Insulin Pump

Tandem Diabetes Care Now Shipping Next-Generation T:slim X2 Insulin Pump

Tandem Diabetes Care®, Inc. (NASDAQ:TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced commencement of shipments for its...

Tandem Diabetes Care Schedules Third Quarter 2016 Earnings Press Release And Conference Call

Tandem Diabetes Care Schedules Third Quarter 2016 Earnings Press Release And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its third quarter 2016 results after the...

Tandem Diabetes Care Now Taking Orders For Next-Generation T:slim X2 Insulin Pump

Tandem Diabetes Care Now Taking Orders For Next-Generation T:slim X2 Insulin Pump

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it is now accepting orders for its...

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:slim G4™ and t:flex® Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will...

Tandem Diabetes Care To Present At The 2016 Wedbush PacGrow Healthcare Conference

Tandem Diabetes Care To Present At The 2016 Wedbush PacGrow Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:slim G4™ and t:flex® Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will...

Tandem Diabetes Care Reports Second Quarter 2016 Financial Results, Updates 2016 Guidance And Announces New T:slim X2™ Insulin Pump And Associated Technology Upgrade Program

Tandem Diabetes Care Reports Second Quarter 2016 Financial Results, Updates 2016 Guidance And Announces New T:slim X2™ Insulin Pump And Associated Technology Upgrade Program

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:slim G4™ and t:flex® Insulin Pumps, today reported its financial results for the quarter ended June 30,...

Tandem Diabetes Care® Announces Expanded Pediatric Indication Of T:slim® Insulin Pump For Ages 6 And Older

Tandem Diabetes Care® Announces Expanded Pediatric Indication Of T:slim® Insulin Pump For Ages 6 And Older

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and the manufacturer of the t:slim®, t:slim G4™ and t:flex® Insulin Pumps, today announced FDA clearance of an expanded pediatric...